Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Movicol versus placebo for constipation associated with irritable bowel syndrome
2008-000550-12Phase 3Completed
- Sponsor
- Norgine
- Start
- Aug 2008
- Modality
- Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in irritable bowel syndrome (IBS) and constipation comparing Movicol with Placebo (2 arms). Primary endpoint: Mean number of spontaneous bowel movements. Started Aug 2008; status: completed.
02
Drugs
polyethylene glycol
03
Conditions
irritable bowel syndrome (IBS)constipation
Beyond the preview
Go deeper on 2008-000550-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000550-12.